Replies to post #346 on OncoVista Innovative Therapies Inc (OVIT)

[sharkgroupsn]

You are speaking of the Camofi case I assume. There has been more legal hurdles. KP pharma etc etc.

Weis is a smart guy. He'll handle it. Forget about OVI-117 and 123. They're dead.

Investors aren't buying it @ 2 cents because it's a obvious winner with a huge pipeline. If you want that stick to the IBB. These opportunities don't come often.